Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0883068
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
Dako ACIS III Cellular Image Acquisition and Analysis System. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. The ability to visualize and analyze cells and tissues from many different animal species, to elucidate both normal and abnormal functions, will be enhanced by the use of this technology. This will lead to production of quantitative statistical data that in turn will ....Dako ACIS III Cellular Image Acquisition and Analysis System. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. The ability to visualize and analyze cells and tissues from many different animal species, to elucidate both normal and abnormal functions, will be enhanced by the use of this technology. This will lead to production of quantitative statistical data that in turn will inform new approaches to improve and maintain the health of humans and other animals.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0347358
Funder
Australian Research Council
Funding Amount
$478,000.00
Summary
Adelaide high-speed cell sorter and analyser facility. Cell sorting and flow cytometric analysis represent powerful and essential tools in modern cell and molecular biology. The applicants seek to develop a core facility within Adelaide University housing a high-speed Fluorescence Activated Cell Sorter and a high-speed flow cytometric analyser. Such a facility is not currently available to researchers in Adelaide. These high-speed machines will allow studies on rare cells and subcellular compon ....Adelaide high-speed cell sorter and analyser facility. Cell sorting and flow cytometric analysis represent powerful and essential tools in modern cell and molecular biology. The applicants seek to develop a core facility within Adelaide University housing a high-speed Fluorescence Activated Cell Sorter and a high-speed flow cytometric analyser. Such a facility is not currently available to researchers in Adelaide. These high-speed machines will allow studies on rare cells and subcellular components, currently not possible on other machines and meeting the demand for access to this sophisticated equipment is vital for cell and molecular biologists in Adelaide to continue advances in genomics and proteomics.Read moreRead less
Retroviral invasion of the koala genome: prevalence, transmission and role in immunosuppressive disease. Koalas are a national symbol yet many of their populations are in decline as a result of habitat loss and disease. Lymphoid cancers and opportunistic infections are significant diseases in both captive and wild koala populations. We previously demonstrated that the recently identified koala retrovirus is associated with lymphoid cancer in koalas. This project will determine the distribution o ....Retroviral invasion of the koala genome: prevalence, transmission and role in immunosuppressive disease. Koalas are a national symbol yet many of their populations are in decline as a result of habitat loss and disease. Lymphoid cancers and opportunistic infections are significant diseases in both captive and wild koala populations. We previously demonstrated that the recently identified koala retrovirus is associated with lymphoid cancer in koalas. This project will determine the distribution of the virus in Australia, the mechanism of its spread and its effect on the immune function of koalas. This research will provide a foundation for better management of captive koalas and for conservation of wild koalas.Read moreRead less
Functional Genomics to Predict and Enhance Response to Interferon. The increasing number and huge cost impost of new therapies to health providers, both worldwide and nationally, has not yet resulted in a concomitant increase in strategies to optimise their use. Many of the new therapies are proteins (recombinant human proteins or humanised monoclonal antibodies). The improved use of one of Australia's most expensive commonly used protein drugs, pegylated interferon ribavirin (Peg-IFN-R), could ....Functional Genomics to Predict and Enhance Response to Interferon. The increasing number and huge cost impost of new therapies to health providers, both worldwide and nationally, has not yet resulted in a concomitant increase in strategies to optimise their use. Many of the new therapies are proteins (recombinant human proteins or humanised monoclonal antibodies). The improved use of one of Australia's most expensive commonly used protein drugs, pegylated interferon ribavirin (Peg-IFN-R), could potentially produce savings to the Pharmaceutical Benefits Scheme (PBS), and improve delivery of healthcare to thousands of Australians.Read moreRead less
Genomic and molecular characterisation of a novel Australian leishmania pathogen. Leishmaniasis is the second most serious protozoal disease after malaria. This project will help characterise the first Leishmania species identified in Australia providing molecular tools to monitor the pathogen and a detailed assessment of any potential risk to human health. Comparative analysis with more pathogenic species will help identify genes and mechanisms that determine the progression of human disease le ....Genomic and molecular characterisation of a novel Australian leishmania pathogen. Leishmaniasis is the second most serious protozoal disease after malaria. This project will help characterise the first Leishmania species identified in Australia providing molecular tools to monitor the pathogen and a detailed assessment of any potential risk to human health. Comparative analysis with more pathogenic species will help identify genes and mechanisms that determine the progression of human disease leading to the potential identification of new drug and vaccine targets. The methodologies and expertise developed will be used will be available to other research groups working on infectious diseases.Read moreRead less
Biotechnology and epidemiology to control nodavirus in barramundi aquaculture. Production of farmed barramundi has increased more than 1200% in the NT since 2001 but is threatened by nodavirus infection. Three industry partners, Darwin Aquaculture Centre, Marine Harvest and Berrimah Veterinary Laboratory will collaborate with The University of Sydney to:
1. control nodavirus infection
2. develop new technologies to detect nodavirus using immunoassay and surface enhanced laser desorption ionis ....Biotechnology and epidemiology to control nodavirus in barramundi aquaculture. Production of farmed barramundi has increased more than 1200% in the NT since 2001 but is threatened by nodavirus infection. Three industry partners, Darwin Aquaculture Centre, Marine Harvest and Berrimah Veterinary Laboratory will collaborate with The University of Sydney to:
1. control nodavirus infection
2. develop new technologies to detect nodavirus using immunoassay and surface enhanced laser desorption ionisation mass spectroscopy (SELDI)
3. develop an integrated disease control strategy based on epidemiological survey data, and ensure that it is practical and able to be widely adopted
By this means growth targets for barramundi aquaculture in northern Australia will be achieved.
Read moreRead less
Engineering of anti-platelet antibodies for the diagnosis and therapy of infants with bleeding disorders. Foeto-maternal alloimmune thrombocytopenia (FMAIT) is a serious clinical condition where infants suffer potentially fatal bleeding disorders from 14 weeks gestation to 1-2 weeks post delivery. The cause of the disease is through maternal antibodies destroying foetal platelets. Our aim is to produce human antibodies, which will be used as diagnostic agents to screen for the condition in preg ....Engineering of anti-platelet antibodies for the diagnosis and therapy of infants with bleeding disorders. Foeto-maternal alloimmune thrombocytopenia (FMAIT) is a serious clinical condition where infants suffer potentially fatal bleeding disorders from 14 weeks gestation to 1-2 weeks post delivery. The cause of the disease is through maternal antibodies destroying foetal platelets. Our aim is to produce human antibodies, which will be used as diagnostic agents to screen for the condition in pregnant women, and to further develop such antibodies for therapy. Identification of mothers at risk of FMAIT and the development of a specific therapy are vital to the management and prevention of this serious condition.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668479
Funder
Australian Research Council
Funding Amount
$265,000.00
Summary
Advanced Imaging Flow Cytometry Facility for NSW. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. Projects where the investigation of single cells is used to elucidate the basic life processes of eukaryotic cells across all species of animals, including the investigation of both normal and abnormal function, will be immeasurably enhanced by both the qualitative and quantitat ....Advanced Imaging Flow Cytometry Facility for NSW. The scientific advances that will be possible with the acquisition of this novel, cutting-edge instrument will enhance the research outputs of all investigators using it. Projects where the investigation of single cells is used to elucidate the basic life processes of eukaryotic cells across all species of animals, including the investigation of both normal and abnormal function, will be immeasurably enhanced by both the qualitative and quantitative statistical information about these processes that is generated by this instrument. This in turn will inform new approaches to improve and maintain the health of the human and animal community.Read moreRead less